Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma

BACKGROUND: This study was conducted to evaluate the efficacy and safety of nimotuzumab combined with chemotherapy as first‐line therapy in advanced lung squamous cell carcinoma (LSCC), and to explore predictive biomarkers of the efficacy of nimotuzumab. METHODS: A retrospective study was conducted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorac Cancer
Hauptverfasser: Si, Xiaoyan, Wu, Shafei, Wang, Hanping, Zhang, Xiaotong, Wang, Mengzhao, Zeng, Xuan, Zhang, Li
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons Australia, Ltd 2018
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6068447/
https://ncbi.nlm.nih.gov/pubmed/29920955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12789
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge